Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Receives Average Rating of "Moderate Buy" from Brokerages

Key Points

• Senseonics has a consensus “Moderate Buy” rating from six analysts, with four buys, one hold and one sell. The average 12-month price target is $17.20, although several firms recently reduced their targets.
• The company reported a quarterly loss of $0.63 per share, missing the $0.55 consensus estimate, on revenue of $14.48 million. Analysts expect a full-year loss of approximately $2.29 per share.
• Shares opened at $9.63, compared with a 52-week range of $4.79 to $11.58; an insider also purchased nearly 14,000 shares for about $125,000, while institutional ownership stands at 12.36%.

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $17.20.

SENS has been the topic of a number of research analyst reports. HC Wainwright lowered their price target on Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a "buy" rating on the stock in a report on Tuesday, May 12th. Weiss Ratings cut shares of Senseonics Holdings, Inc. Common Stock from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, August 12th. Wall Street Zen raised shares of Senseonics Holdings, Inc. Common Stock from a "strong sell" rating to a "sell" rating in a report on Saturday, August 8th. Mizuho cut their target price on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an "outperform" rating for the company in a research note on Wednesday, July 15th. Finally, Stifel Nicolaus reduced their price target on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Monday, May 11th.

Senseonics Holdings, Inc. Common Stock Price Performance

NASDAQ:SENS opened at $9.63 on Friday. The business's 50-day simple moving average is $6.73 and its two-hundred day simple moving average is $6.66. Senseonics Holdings, Inc. Common Stock has a 52 week low of $4.79 and a 52 week high of $11.58. The stock has a market cap of $402.53 million, a PE ratio of -4.32 and a beta of 1.08. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.63) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 165.80% and a negative net margin of 225.09%.The business had revenue of $14.48 million during the quarter. As a group, analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.29 EPS for the current fiscal year.

Insider Activity at Senseonics Holdings, Inc. Common Stock

In other news, Director Douglas Roeder acquired 13,953 shares of the business's stock in a transaction dated Wednesday, August 19th. The stock was purchased at an average price of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the transaction, the director directly owned 171,191 shares in the company, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 4.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Kestra Advisory Services LLC purchased a new position in Senseonics Holdings, Inc. Common Stock during the 1st quarter valued at approximately $68,000. GSK plc bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the 4th quarter valued at approximately $60,000. The Manufacturers Life Insurance Company purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at $65,000. State of Wyoming purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at $67,000. Finally, Cetera Investment Advisers bought a new stake in Senseonics Holdings, Inc. Common Stock in the first quarter worth $85,000. 12.36% of the stock is owned by institutional investors.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source